Clinical trial
Anterior Segment- Optical Coherence Tomography as Early Biomarker in Diabetic Retinopathy
NCT04992325 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anterior Segment- Optical Coherence Tomography as Early Biomarker in Diabetic Retinopathy
- Lead sponsor
- Federico II University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2020
- Completion date
- April 30, 2021
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.